Not Signed In -
Head Lice |
Lice; Lice Infestation |
The head louse Head lice (Pediculus humanus capitis) are one of the many varieties of sucking lice (singular "louse") specialized to live on different areas of various animals. As the name implies, head lice are specialized to live among the hair present on the human head and are exquisitely adapted to living mainly on the scalp and neck hairs of their human host. Lice present on other body parts covered by hair are not head lice but are either Pubic lice (Pthirus pubis) or Body lice ( ...
Wikipedia - [full article]
Head Lice Clinical Trials
- A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
ClinicalTrials.gov Identifier: NCT00528021 - Recruiting
Pediculus Humanus Capitis; Head Lice
- Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
ClinicalTrials.gov Identifier: NCT00244439 - Active, not recruiting
Lice Infestations
- Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
ClinicalTrials.gov Identifier: NCT00291057 - Active, not recruiting
Lice Infestations
- Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.
ClinicalTrials.gov Identifier: NCT00301327 - Completed
Head Lice
- Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
ClinicalTrials.gov Identifier: NCT00301340 - Completed
Head Lice
- Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
ClinicalTrials.gov Identifier: NCT00479310 - Completed
Head Lice
- Safety and Efficacy Study of NatrOVA - 1% Creme Rinse and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
ClinicalTrials.gov Identifier: NCT00545753 - Recruiting
Pediculosis Capitis(Head Lice)
- A Comparative Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Pediculosis Capitis
ClinicalTrials.gov Identifier: NCT00545168 - Recruiting
Pediculosis Capitis (Head Lice)
- Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00120211 - Active, not recruiting
Head and Neck Cancer
- A PK Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age
ClinicalTrials.gov Identifier: NCT00410709 - Completed
Pediculosis Capitis (Head Lice)
- A Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction of Oral Mucositis in Subjects with Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00131638 - Active, not recruiting
Head and Neck Cancer
- Clinical Trial of New Elastomer for Maxillofacial Prosthetics
ClinicalTrials.gov Identifier: NCT00123097 - Active, not recruiting
Facial Neoplasms; Head and Neck Neoplasms; Head Injuries, Penetrating; Birth Injuries
- Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
ClinicalTrials.gov Identifier: NCT00052611 - Active, not recruiting
Head and Neck Cancer
- Ixabepilone in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00033618 - Active, not recruiting
Head and Neck Cancer
- Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00062387 - Active, not recruiting
Head and Neck Cancer
- Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00100789 - Active, not recruiting
Head and Neck Cancer
- Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00040807 - Active, not recruiting
Head and Neck Cancer
- Problems With Morphine Use in Patients With a Severe Brain Injury
ClinicalTrials.gov Identifier: NCT00196131 - Active, not recruiting
Head Trauma; Subarachnoid Hemorrhage; Close Head Injury
- Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00521521 - Active, not recruiting
Head and Neck Neoplasms
- Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
ClinicalTrials.gov Identifier: NCT00230256 - Active, not recruiting
Head and Neck Cancer
- A Phase 2 Clinical Trial of the Effectiveness of IRX-2 in Treating Patients With Operable Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00210470 - Active, not recruiting
Squamous Cell Carcinoma of the Head and Neck
- Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00024089 - Active, not recruiting
Head and Neck Cancer
- Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00098631 - Active, not recruiting
Head and Neck Cancer
- Head Injury Retrieval Trial
ClinicalTrials.gov Identifier: NCT00112398 - Recruiting
Head Injuries, Closed
- Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
Head and Neck Cancer
- A Study of TNFerade™ With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00496535 - Recruiting
Head and Neck Cancer; Head and Neck Neoplasms
- OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
ClinicalTrials.gov Identifier: NCT00076310 - Active, not recruiting
Head and Neck Cancer
- Study to Evaluate Palifermin for the Reduction of Oral Mucositis in Subjects with Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00101582 - Active, not recruiting
Head and Neck Cancer; Squamous Cell Carcinoma
- Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00496236 - Recruiting
Head and Neck Cancer; Head and Neck Neoplasms
- Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00248235 - Active, not recruiting
Head and Neck Neoplasms
- Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055770 - Active, not recruiting
Head and Neck Cancer
- Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003489 - Active, not recruiting
Head and Neck Cancer
- Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00002476 - Active, not recruiting
Oropharyngeal Cancer; Head and Neck Cancer; lip and oral cavity cancer
- Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00135161 - Active, not recruiting
neoplasms (squamous cell carcinoma of the head and neck region)
- Neoadjuvant Docetaxel Plus Cisplatin and 5-Fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS).
ClinicalTrials.gov Identifier: NCT00357149 - Active, not recruiting
Head and Neck Neoplasms
- Capecitabine in Treating Patients Who Have Undergone Previous Surgery, Radiation Therapy, and/or Chemotherapy for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00258310 - Active, not recruiting
Head and Neck Cancer
- Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00301028 - Active, not recruiting
Head and Neck Cancer
- Cisplatin, Fluorouracil, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00352105 - Active, not recruiting
Head and Neck Cancer
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00004097 - Active, not recruiting
lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00009841 - Active, not recruiting
lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00415298 - Active, not recruiting
Head and Neck Cancer
- Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
ClinicalTrials.gov Identifier: NCT00002695 - Active, not recruiting
Lip Neoplasms; Mouth Neoplasms; Oropharyngeal Cancer; Head and Neck Cancer
- A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis
ClinicalTrials.gov Identifier: NCT00311779 - Completed
Pediculosis Capitis (Head Lice)
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00405405 - Recruiting
Head and Neck Cancer.; Parotid Gland, Thyroid Gland and Melanoma Cases; Stage IV Head and Neck Caner
- Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00198263 - Active, not recruiting
Head and Neck Cancer
- Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00167908 - Active, not recruiting
Head and Neck Cancer
- Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00448552 - Active, not recruiting
Head and Neck Cancer
- Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00006107 - Active, not recruiting
Head and Neck Cancer
- Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00068497 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00337129 - Active, not recruiting
Head and Neck Cancer
- Head to Head Study Against Sevelamer Hydrochloride
ClinicalTrials.gov Identifier: NCT00441545 - Recruiting
Chronic Kidney Disease, Stage 5
- Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00415025 - Active, not recruiting
Head and Neck Cancer; Long-Term Effects Secondary to Cancer Therapy in Adults; Oral Complications of Cancer and Cancer Therapy; Oral Complications of Chemotherapy and Head/Neck Radiation; Radiation Toxicity
- Study of ABT-510 (Thrombospondin Analogue) in Patients with Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00113334 - Active, not recruiting
Head and Neck Cancer
- GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00293462 - Recruiting
Head and Neck Cancer; Oral Complications of Chemotherapy and Head/Neck Radiation; Radiation Toxicity
- Biobank Head and Neck Cancer: Storing Blood for Analysis of DNA and Protein of Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00181428 - Recruiting
Head and Neck Cancer
- Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
ClinicalTrials.gov Identifier: NCT00559156 - Active, not recruiting
Head and Neck Cancer
- FR901228 in Treating Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma (Cancer) of the Head and Neck
ClinicalTrials.gov Identifier: NCT00084682 - Recruiting
Head and Neck Cancer
- Patient Evaluation for Head and Neck Surgery Branch Studies
ClinicalTrials.gov Identifier: NCT00011492 - Recruiting
Head and Neck Cancer
- Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area
ClinicalTrials.gov Identifier: NCT00180934 - Active, not recruiting
Recurrence of Head and Cancer in Irraiated Area
- Optimized Intensity Modulated Irradiation for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00580983 - Enrolling by invitation
Head and Neck Cancer
- Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
Head and Neck Cancer
- ExploR® Modular Radial Head Data Collection
ClinicalTrials.gov Identifier: NCT00533234 - Recruiting
Degenerative Conditions of the Radial Head/Neck; Post-Traumatic Conditions of the Radial Head/Neck
- Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
ClinicalTrials.gov Identifier: NCT00168116 - Active, not recruiting
Head and Neck Cancer
- Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
ClinicalTrials.gov Identifier: NCT00544414 - Active, not recruiting
Head and Neck Cancer
- Erlotinib and Docetaxel with Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov Identifier: NCT00113347 - Recruiting
Head and Neck Cancer
- Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00004070 - Active, not recruiting
lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- Diagnostic Algorithm in Patients With Minor Head Injury
ClinicalTrials.gov Identifier: NCT00452036 - Active, not recruiting
Minor Head Injury; Traumatic Brain Injury
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00352118 - Recruiting
Head and Neck Cancer; Mucositis; Oral Complications of Chemotherapy and Head/Neck Radiation
- Study of SCH 54031 in Surgically Resectable Squamous Cell Tumors of the Head and Neck
ClinicalTrials.gov Identifier: NCT00078416 - Recruiting
Head and Neck Cancer
- Measuring Head Impacts in Sports
ClinicalTrials.gov Identifier: NCT00060827 - Active, not recruiting
Brain Injuries; Brain Concussion
- Angiogenic and EGFR Blockade with Curative Chemoradiation for Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00140556 - Recruiting
Head and Neck Cancer; Cancer of the Head and Neck; upper aerodigestive tract neoplasms; Pharynx Cancer; Pharynx Neoplasms
- SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
ClinicalTrials.gov Identifier: NCT00006361 - Active, not recruiting
lip and oral cavity cancer; Skin Cancer; Head and Neck Cancer; Oropharyngeal Cancer
- Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00103259 - Recruiting
Head and Neck Cancer
- Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries
ClinicalTrials.gov Identifier: NCT00006128 - Recruiting
Head Injuries, Closed
- Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
Head and Neck Cancer
- Reducing Seizure Frequency Using Cooling of the Head and Neck
ClinicalTrials.gov Identifier: NCT00067210 - Active, not recruiting
Epilepsy; Seizures
- PET Imaging in Post Radiation Evaluation of Head and Neck Tumours "PET PREVENT"
ClinicalTrials.gov Identifier: NCT00147472 - Recruiting
Cancer of the Head and Neck
- Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003251 - Active, not recruiting
Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- Vietnam Head Injury Study - Phase III
ClinicalTrials.gov Identifier: NCT00132249 - Recruiting
Traumatic Brain Injury; Penetrating head wounds; Closed Head Trauma; TBI
- Screening Trial to Study Eligibility of Patients to Participate in Head and Neck Surgery Clinical Trials
ClinicalTrials.gov Identifier: NCT00045071 - Recruiting
Head and Neck Cancer
- Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00199160 - Recruiting
Head and Neck Neoplasms
- Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-Based Contrast
ClinicalTrials.gov Identifier: NCT00230295 - Recruiting
Head and Neck Cancer
- S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00252473 - Recruiting
Head and Neck Neoplasms
- Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
ClinicalTrials.gov Identifier: NCT00266279 - Recruiting
Head & Neck Cancer
- Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)
ClinicalTrials.gov Identifier: NCT00304278 - Recruiting
Head and Neck Cancer
- Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00358007 - Recruiting
Head and Neck Tumors
- C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00402545 - Recruiting
Head and Neck Neoplasms
- The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
ClinicalTrials.gov Identifier: NCT00230269 - Recruiting
Head and Neck Cancer
- BIBW 2992 in Head&Neck Cancer
ClinicalTrials.gov Identifier: NCT00514943 - Recruiting
Head and Neck Neoplasms; Carcinoma, Squamous Cell
- Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation
ClinicalTrials.gov Identifier: NCT00577902 - Recruiting
Head and Neck Cancer
- A Trial to Investigate the Biodistribution and Pharmacokinetics of F-18 Flurothymidine(FLT) and Calculate the Radiation Dosimetry for Critical Organs in Subjects With Head and Neck Cancer.
ClinicalTrials.gov Identifier: NCT00245349 - Recruiting
Head and Neck Squamous Cell Carcinoma
- Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
ClinicalTrials.gov Identifier: NCT00185835 - Active, not recruiting
Head and Neck Cancer; Carcinoma, Squamous Cell
- A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00358930 - Active, not recruiting
Head and Neck Neoplasms; Carcinoma, Squamous Cell
- A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer
ClinicalTrials.gov Identifier: NCT00371566 - Recruiting
Squamous Cell Carcinoma of Head and Neck
- Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00519077 - Recruiting
Head and Neck Neoplasms
- Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00003264 - Active, not recruiting
Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- Molecular Classification of Head and Neck Squamous Cell Carcinoma Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy
ClinicalTrials.gov Identifier: NCT00200486 - Recruiting
Cancer of Head and Neck
- PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
ClinicalTrials.gov Identifier: NCT00454779 - Recruiting
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
- PET/CT to Image Hypoxia in Head and Neck Tumours
ClinicalTrials.gov Identifier: NCT00395109 - Recruiting
Head and Neck Cancer.
email this page
print this page
bookmark this page
feedback on this page
